Back to Newsroom

SiteOne Therapeutics Completes $1.5M Initial Round of Equity Financing, Secures $1.4M NIH Grant

SAN FRANCISCO, Sept. 23, 2014 — SiteOne Therapeutics Inc. today announced the completion of its initial round of equity financing. Led by Sears Capital Management and Biobrit LLC, with additional investors Mission Bay Capital and Joe Zakrzewski, the $1.5 million financing positions SiteOne to advance its oral NaV1.7 inhibitor program for pain and to further develop its technology platform for long-acting local analgesics, pain diagnostics and other pain indications.

Click here to read more